Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03650491
Title A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Fortis Therapeutics, Inc.
Indications

multiple myeloma

Therapies

FOR46

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.